Adia Med, Inc.
Close on Oct 19, 2026
- Market cap
- $20.98M
- P/E (TTM)
- –
- Dividend yield
- –
About Adia Med
Medicinal Chemicals & Botanical Products, SIC 2833
ADIA Nutrition, Inc. is a biotechnology and healthcare company specializing in regenerative medicine and dietary supplements. The company operates primarily through its Adia Med and Adia Labs divisions. Adia Med delivers regenerative medical therapies, including Autologous Hematopoietic Stem Cell Transplantation (AHSCT) and Umbilical Cord Stem Cell procedures, to patients through specialized clinical locations. Adia Labs procures and distributes biologic products, including its proprietary AdiaVita and AdiaLink offerings, to healthcare facilities and research professionals. Beyond its biologics business, the enterprise distributes organic dietary supplements directly to consumers through an equity interest in a nutrition company. The firm serves patients, medical practitioners, researchers, and retail wellness consumers.
The enterprise operates a medical treatment clinic in Winter Park, Florida, and procures perinatal materials through accredited cord-blood banks across the United States. Its primary executive offices are located in Winter Park, Florida.
Summary of the business section of Adia Med's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Adia Med, Inc.
- Founded
- 1975
- Headquarters
- Winter Park, FL
- Address
- 4421 Gabriella Lane 32792
- Phone
- (321) 231-2843
- Website
- cementfactory.co
- Employees
- 3, Dec 31, 2025
- Industry
- Medicinal Chemicals & Botanical Products
- Incorporated in
- Nevada
- Fiscal year ends
- December 31
- Auditor
- Astra Audit & Advisory, Tampa, Florida
Stock & identifiers
- Ticker
- ADIA
- Exchange
- OTC
- Shares outstanding
- 94M, Aug 13, 2026
- Public float
- $5.63M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- SEC CIK
- 1160420
- CUSIP
- 00687W109
- ISIN
- US00687W1099
- EIN
- 87-0675769
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
Adia Med's leadership is listed in its proxy statement (Form DEF 14A).
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Oct 6, 2026 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Aug 24, 2026 | Name change | Name changed from Adia Nutrition, Inc. to Adia Med, Inc. |
| Jul 17, 2013 | Name change | Name changed from PivX Solutions, Inc. to Adia Nutrition, Inc. |
| Sep 25, 2008 | Deregistration | Termination of SEC registration (Form 15) |
| Jul 1, 2008 | Late filing | Notification of late filing |
| Jan 25, 2008 | Late filing | Notification of late filing |
| Oct 1, 2007 | Late filing | Notification of late filing |
| Nov 15, 2005 | Late filing | Notification of late filing |
| Aug 16, 2005 | Late filing | Notification of late filing |
| Jun 2, 2005 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| May 16, 2005 | Late filing | Notification of late filing |
| Apr 15, 2005 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Apr 7, 2005 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Apr 1, 2005 | Late filing | Notification of late filing |
| Jan 20, 2005 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Aug 30, 2004 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Aug 24, 2004 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Aug 17, 2004 | Late filing | Notification of late filing |
| May 18, 2004 | Late filing | Notification of late filing |
| Apr 21, 2004 | Name change | Name changed from DRILLING INC to PivX Solutions, Inc. |